1. Band PR, Maroun J, Pritchard K, Stewart D, Coppin CM, Wilson K, Eisenhauer EA (1986) Phase II study of lonidamine in patients with metastatic breast cancer. Cancer Treat Rep 70:1305
2. Batist G, Tulpule A, Sinha BK, Katki AG, Myers CE, Cowan KH (1986) Induction of an anionic GSH-S-transferase in multidrug-resistant human breast cancer cells and in xenobiotic-resistant preneoplastic liver nodules induced by carcinogens. J Biol Chem 261:15544
3. Bertetto O, Villois MT, Valle A, Zerbi R, Clerito M, Calciati A (1987) Phase II study with lonidamine in advanced head and neck (H&N) squamous cell carcinoma. Proc 4th Europ Conf Clin Oncol Nursing Abstract 488, Madrid, Spain
4. Breau JL, Morere JF, Israel L (1988) Chemotherapy with or without lonidamine for induction therapy in squamous cell carcinoma of the lung. A randomised study comparing cisplatinum-bleomycin or cisplatinum-bleomycin-VP16 213 (±lonidamine). Proc Am Soc Clin Oncol 7:819
5. Bubenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J (1973) Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer 11:765